Suzanne Lentzch (Suzanne Lentzsch)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Multiple Myeloma

African American

Monoclonal Antibody

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Blood cancer journal

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzch, Rachid C Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca W Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquin Martinez Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, Madhav V Dhodapkar
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Jing Fu, Shirong Li, Huihui Ma, Jun Yang, Gabriel M Pagnotti, Lewis M Brown, Stephen J Weiss, Markus Y Mapara, Suzanne Lentzch
The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease. Nature communications 14 (1) (2023)
Shaji K Kumar, Lawrence Baizer, Natalie S Callander, Sergio A Giralt, Jens Hillengass, Boris Freidlin, Antje Hoering, Paul Gerard Richardson, Elena I Schwartz, Anthony Reiman, Suzanne Lentzch, Philip L McCarthy, Sundar Jagannath, Andrew J Yee, Richard F Little, Noopur S Raje
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee. Blood cancer journal 12 (6) (2022)
Rajshekhar Chakraborty, Suzanne Lentzch
Circulating Tumor Cell Burden as a Component of Staging in Multiple Myeloma: Ready for Prime Time? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (27) (2022)
Kara I Cicero, Maureen Joffe, Moosa Patel, Codruta Chiuzan, Audrey Pentz, Paul Ruff, Suzanne Lentzch, Siyang Leng, Judith S Jacobson, Timothy R Rebbeck, Alfred I Neugut
Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (12) (2022)
Madeleine B Hopson, Divaya Bhutani, Shawn Sarkaria, Mathew S Maurer, Jan M Griffin, Markus Mapara, Suzanne Lentzch, Rajshekhar Chakraborty
Impact of light chain isotype on clinical features and outcomes in systemic AL amyloidosis. Leukemia & lymphoma 63 (9) (2022)
Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan O Schönland, Kaya Veelken, Ute Hegenbart, Susan M Geyer, Shaji K Kumar, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzch, Alexander Coltoff, Joan Bladé, Maria Teresa Cibeira, Oliver Cohen, Darren Foard, Ashutosh Wechalekar, Morie A Gertz
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Camille V Edwards, Nisha Rao, Divava Bhutani, Markus Y Mapara, Jai Radhakrishnan, Sofia Shames, Mathew S Maurer, Siyang Leng, Alan Solomon, Suzanne Lentzch, Andrew Eisenberger
Phase 1a/b Study of Monoclonal Antibody CAEL-101 (11-1F4) in Patients with AL Amyloidosis. Blood (2021)
Carlos Fernández de Larrea, Robert Kyle, Laura Rosinol, Juan José Lahuerta, Monika Engelhardt, Saad Z Usmani, Jo Caers, Wilson Gonsalves, Schjesvold Fredrik, Giampaolo Merlini, Suzanne Lentzch, Enrique Ocio, Laurent Garderet, Philippe Moreau, Pieter Sonneveld, Ashraf Badros, Gösta Gahrton, Hartmut Goldschmidt, Sascha A Tuchman, Hermann Einsele, Brian Durie, Baldeep Wirk, Pellegrino Musto, Patrick Hayden, Martin F Kaiser, Jesús San F Miguel, Joan Bladé, Sundararajan Vincent Rajkumar, Maria-Victoria Mateos-Manteca
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood cancer journal 11 (12) (2021)
Vikram J Premkumar, Suzanne Lentzch, Samuel Pan, Divaya Bhutani, Joshua Richter, Sundar Jagannath, Michaela Liedtke, Arnaud Jaccard, Ashutosh D Wechalekar, Raymond Comenzo, Vaishali Sanchorawala, Bruno Royer, Michael Rosenzweig, Jason Valent, Stefan O Schönland, Rafael Fonseca, Sandy Wong, Prashant Kapoor
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood cancer journal 11 (1) (2021)
Camille Vanessa Edwards, Divaya Bhutani, Markus Mapara, Jai Radhakrishnan, Sofia Shames, Mathew S Maurer, Siyang Leng, Jonathan S Wall, Alan Solomon, Andrew Eisenberger, Suzanne Lentzch
One year follow up analysis of the phase 1a/b study of chimeric fibril-reactive monoclonal antibody 11-1F4 in patients with AL amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 26 (sup1) (2020)
Suzanne Lentzch, Galina G Lagos, Raymond L Comenzo, Jeffrey A Zonder, Silva Pregja, Keren Osman, Wei-Yann Tsai, Heather Landau, Vaishali Sanchorawala
Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis 26 (sup1) (2020)
Rajshekhar Chakraborty, Suzanne Lentzch
Emerging drugs for the treatment of light chain amyloidosis. Expert opinion on emerging drugs 25 (3) (2020)
Shirong Li, Jing Fu, Hui Wang, Huihui Ma, Xiaoming Xu, Yong-Guang Yang, Shixian Deng, Markus Y Mapara, Suzanne Lentzch
IMiD compounds affect CD34+ cell fate and maturation via CRBN-induced IKZF1 degradation. Blood advances 2 (5) (2019)
Shirong Li, Sonia Vallet, Antonio Sacco, Aldo Roccaro, Suzanne Lentzch, Klaus Podar
Targeting transcription factors in multiple myeloma: evolving therapeutic strategies. Expert opinion on investigational drugs 28 (5) (2019)
Siyang Leng, Suzanne Lentzch, Yanhan Shen, Wei-Yann Tsai, Jason Dennis Wright, Dawn Lauryn Hershman, Alfred I Neugut
Use and impact of herpes zoster prophylaxis in myeloma patients treated with proteasome inhibitors. Leukemia & lymphoma 59 (10) (2018)